DoHDA’s plan to require online prescribers to upload medicines data to My Health Record, reinforced by ADHA’s 24 percent staff lift and new Assignment of Benefit rules, makes interoperable medicines flows, consent capture and audit trails an immediate operational priority for Australian GP software, telehealth platforms and device integrators.

Interoperability must-have

Three separate policy moves this week — DoHDA’s telehealth medicines record reform, the Commission’s stroke aftercare standard and ADHA’s expanded resourcing — together create a regulatory runway that demands end-to-end data links. Vendors that already support ePrescribing, Active Script List and My Health Record integrations are advantaged because health services will prioritise systems that reduce clinical risk and ease mandatory reporting. Practices and smaller vendors without modern APIs face procurement exclusion or costly retrofit projects. Momentum is building: multiple final dates and staff capacity are moving from aspiration to implementation, so buying decisions out of next quarter should assume conformance and security as minimum viable features.

Billing and compliance

Tighter financial controls landed twice this week. From 1 July bulk-billed claims must include a pre-capture Assignment of Benefit and a signed record kept for two years. That, plus larger penalties and clearer TGA guidance for compounding pharmacies, turns administrative flows into compliance bottlenecks. Practice management systems that can capture AoB, store signatures and produce audit logs will win new contracts. Clinics still relying on manual front‑desk processes are pressured to automate or accept higher legal and financial risk. The policy choices practices make now will determine whether they keep billing simple or face disruptive system replacement later.

Adoption limits

The upbeat case for remote monitoring and AI met a reality check. Technical innovation — from UNSW’s AusculPatch and Miya Precision’s RPM roll‑outs to rapid telehealth growth reported by Hola Health — sits alongside stark constraints. OAIC’s privacy report shows trust in AI at 4 percent and a spike in complaints. Allied health still uses paper at scale. The RDTI ten‑year cap debate and AstraZeneca’s sponsor‑run Zoladex access program both show funding and commercial models can centralise control or reduce investment appetite. The consequence is clear: even as interoperability becomes mandatory, uptake will stall where trust, workforce capability and financing are weak. Vendors must build consent, explainability and low‑touch training into deployments, and procurement teams need to budget for governance and change management, not just software licences.